Rehabilitation treatment options for a patient with paraneoplastic cerebellar degeneration von PERLMUTTER, Erica, GREGORY, Patricia C

Volltext

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial von Pusztai, Lajos, Yau, Christina, Wolf, Denise M., Han, Hyo S., Du, Lili, Wallace, Anne M., String-Reasor, Erica, Boughey, Judy C., Chien, A. Jo, Elias, Anthony D., Beckwith, Heather, Nanda, Rita, Albain, Kathy S., Clark, Amy S., Kemmer, Kathleen, Kalinsky, Kevin, Isaacs, Claudine, Thomas, Alexandra, Shatsky, Rebecca, Helsten, Theresa L., Forero-Torres, Andres, Liu, Minetta C., Brown-Swigart, Lamorna, Petricoin, Emmanuel F., Wulfkuhle, Julia D., Asare, Smita M., Wilson, Amy, Singhrao, Ruby, Sit, Laura, Hirst, Gillian L., Berry, Scott, Sanil, Ashish, Asare, Adam L., Matthews, Jeffrey B., Perlmutter, Jane, Melisko, Michelle, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Yee, Doug, van’t Veer, Laura J., Hylton, Nola M., DeMichele, Angela M., Berry, Donald A., Esserman, Laura J.

Volltext

Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial von Wei, Chenchen, Wang, Jeffrey, Foster, Lydia D., Yeatts, Sharon D., Moy, Claudia, Mocco, J, Selim, Magdy

Volltext

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease von McGarry, Andrew, McDermott, Michael, Kieburtz, Karl, de Blieck, Elisabeth A., Beal, Flint, Marder, Karen, Ross, Christopher, Shoulson, Ira, Gilbert, Peter, Mallonee, William M., Guttman, Mark, Wojcieszek, Joanne, Kumar, Rajeev, LeDoux, Mark S., Jenkins, Mary, Rosas, H. Diana, Nance, Martha, Biglan, Kevin, Como, Peter, Dubinsky, Richard M., Shannon, Kathleen M., OʼSuilleabhain, Padraig, Chou, Kelvin, Walker, Francis, Martin, Wayne, Wheelock, Vicki L., McCusker, Elizabeth, Jankovic, Joseph, Singer, Carlos, Sanchez-Ramos, Juan, Scott, Burton, Suchowersky, Oksana, Factor, Stewart A., Higgins, Donald S., Molho, Eric, Revilla, Fredy, Caviness, John N., Friedman, Joseph H., Perlmutter, Joel S., Feigin, Andrew, Anderson, Karen, Rodriguez, Ramon, McFarland, Nikolaus R., Margolis, Russell L., Farbman, Eric S., Raymond, Lynn A., Suski, Valerie, Kostyk, Sandra, Colcher, Amy, Seeberger, Lauren, Epping, Eric, Esmail, Sherali, Diaz, Nancy, Fung, Wai Lun Alan, Diamond, Alan, Frank, Samuel, Hanna, Philip, Hermanowicz, Neal, Dure, Leon S., Cudkowicz, Merit

Volltext

Biomarkers predicting response to 5 immunotherapy arms in the neoadjuvant I-SPY2 trial for early-stage breast cancer (BC): Evaluation of immune subtyping in the response predictive... von Wolf, Denise M., Yau, Christina, Campbell, Michael J., Glas, Annuska M., Mittempergher, Lorenza, Kuilman, Midas M., Barcaru, Andrei, Brown Swigart, Lamorna, Nanda, Rita, Chien, Amy Jo, Pusztai, Lajos, Stringer-Reasor, Erica Michelle, Shatsky, Rebecca Arielle, Isaacs, Claudine, Perlmutter, Jane, DeMichele, Angela, Yee, Douglas, Esserman, Laura, van 't Veer, Laura

Volltext

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-... von Magbanua, Mark Jesus M., van ‘t Veer, Laura, Clark, Amy S., Chien, A. Jo, Boughey, Judy C., Han, Hyo S., Wallace, Anne, Beckwith, Heather, Liu, Minetta C., Yau, Christina, Wileyto, E. Paul, Ordonez, Andrea, Solanki, Tulasi I., Hsiao, Feng, Lee, Jen Chieh, Basu, Amrita, Brown Swigart, Lamorna, Perlmutter, Jane, Delson, Amy L., Bayne, Lauren, Deluca, Shannon, Yee, Stephanie S., Carpenter, Erica L., Esserman, Laura J., Park, John W., Chodosh, Lewis A., DeMichele, Angela

Volltext

Why Are Women Less Represented in Intracerebral Hemorrhage Trials? von Greige, Tatiana, Norton, Casey, Foster, Lydia D., Yeatts, Sharon D., Thornhill, Andre, Griffin, Jessica, Wang, Jeffrey, Hrdlicka, Courtney M., Selim, Magdy

Volltext

Dystonia treatment: Patterns of medication use in an international cohort von Pirio Richardson, Sarah, Wegele, Ashley R, Skipper, Betty, Deligtisch, Amanda, Jinnah, H A

Volltext

Abstract PS2-07: Outcomes associated with disseminated tumor cells at surgery after neoadjuvant chemotherapy in high-risk early stage breast cancer: The I-SPY SURMOUNT study von Magbanua, Mark Jesus M, van 't Veer, Laura, Clark, Amy, Chien, A. Jo, Boughey, Judy, Han, Heather, Wallace, Anne, Beckwith, Heather, Liu, Minetta, Yau, Christina, Wileyto, E. Paul, Swigart, Lamorna Brown, Perlmutter, Jane, Bayne, Lauren, Deluca, Shannon, Yee, Stephanie, Carpenter, Erica, Esserman, Laura, Park, John, Chodosh, Lewis, DeMichele, Angela

Volltext

Abstract PD1-10: Evaluation of SGN-LIV1a followed by AC in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL von Beckwith, Heather, Schwab, Richard, Yau, Christina, Stringer-Reasor, Erica, Wei, Shi, Chien, A. Jo, Albain, Kathy S, Kalinsky, Kevin, Wallace, Anne, Elias, Anthony, Yee, Douglas, Clark, Amy S, Boughey, Judy C, Han, Heather, Nanda, Rita, Isaacs, Claudine, Mitri, Zahi, Lang, Julie E, Thomas, Alexandra, Sanft, Tara, DeMichele, Angela, Perlmutter, Jane, Rugo, Hope S, Hylton, Nola M, Symmans, W. Fraser, Melisko, Michelle E, van't Veer, Laura J, Wilson, Amy, Asare, Smita M, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Volltext

Identifying treatment options for BRAF.sup.V600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial von LoRusso, Patricia M, Sekulic, Aleksandar, Sosman, Jeffrey A, Liang, Winnie S, Carpten, John, Craig, David W, Solit, David B, Bryce, Alan H, Kiefer, Jeffrey A, Aldrich, Jessica, Nasser, Sara, Halperin, Rebecca, Byron, Sara A, Pilat, Mary Jo, Boerner, Scott A, Durecki, Diane, Hendricks, William P. D, Enriquez, Daniel, Izatt, Tyler, Keats, Jonathan, Legendre, Christophe, Markovic, Svetomir N, Weise, Amy, Naveed, Fatima, Schmidt, Jessica, Basu, Gargi D, Sekar, Shobana, Adkins, Jonathan, Tassone, Erica, Sivaprakasam, Karthigayini, Zismann, Victoria, Calvert, Valerie S, Petricoin, Emanuel F, Fecher, Leslie Anne, Lao, Christopher, Eder, J. Paul, Vogelzang, Nicholas J, Perlmutter, Jane, Gorman, Mark, Manica, Barbara, Fox, Lisa, Schork, Nicholas, Zelterman, Daniel, DeVeaux, Michelle, Joseph, Richard W, Cowey, C. Lance, Trent, Jeffrey M

Volltext

Abstract P3-11-02: Evaluation of patritumab/paclitaxel/trastuzumab over standard paclitaxel/trastuzumab in early stage, high-risk HER2 positive breast cancer: Results from the neoa... von Helsten, Teresa L, Lo, Shelly S, Yau, Christina, Kalinsky, Kevin, Elias, Anthony D, Wallace, Anne M, Chien, A. Jo, Lu, Janice, Lang, Julie E, Albain, Kathy S, Stringer-Reasor, Erica, Clark, Amy S, Boughey, Judy C, Ellis, Erin D, Yee, Douglas, DeMichele, Angela, Isaacs, Claudine, Perlmutter, Jane, Rugo, Hope S, Schwab, Richard, Hylton, Nola M., Symmans, W. Fraser, Melisko, Michelle E, van't Veer, Laura J, Wilson, Amy, Singhrao, Ruby, Asare, Smita M, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Volltext

Abstract CT011: Evaluation of durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL von Pusztai, Lajos, Han, Hyo S., Yau, Christina, Wolf, Denise, Wallace, Anne M., Shatsky, Rebecca, Helsten, Teresa, Boughey, Judy C., Haddad, Tufia, Stringer-Reasor, Erica, Falkson, Carla, Chien, A. Jo, Mukhtar, Rita, Elias, Anthony, Virginia, Borges, Nanda, Rita, Yee, Douglas, Kalinsky, Kevin, Albain, Kathy S., Muller, Aixa Soyano, Kemmer, Kathleen, Clark, Amy S., Isaacs, Claudine, Thomas, Alexandra, Hylton, Nola, Symmans, W. Fraser, Perlmutter, Jane, Melisko, Michelle, Rugo, Hope S., Schwab, Richard, Wilson, Amy, Singhrao, Ruby, Asare, Smita, van't Veer, Laura J., DeMichele, Angela M., Sanil, Ashish, Berry, Donald A., Esserman, Laura J.

Volltext

Abstract P2-20-02: Site of recurrence after neoadjuvant therapy: Clues to biology and impact on endpoints von Yau, Christina, DeMichele, Angela, Symmans, W. Fraser, Pusztai, Lajos, Yee, Douglas, Clark, Amy S., Hatzis, Christos, Matthews, Jeffrey B., Carter, Jodi, Chen, Yunn-Yi, Cole, Kimberly, Khazai, Laila, Klein, Molly, Kokh, Dina, Krings, Gregor, Sahoo, Sunati, Albain, Kathy S., Chien, A. Jo, Edmiston, Kirsten K., Elias, Anthony D., Ellis, Erin D., Euhus, David M., Han, Heather S., Isaacs, Claudine, Khan, Qamar J., Lang, Julie E., Lu, Janice, Meisel, Jane L., Mitri, Zaha, Nanda, Rita, Northfelt, Donald W., Sanft, Tara, Stringer-Reasor, Erica, Viscusi, Rebecca K., Wallace, Anne M., Yung, Rachel, Hylton, Nola M., Boughey, Judy C., Melisko, Michelle E., Perlmutter, Jane, Rugo, Hope S., Schwab, Richard, van' t Veer, Laura J., Berry, Donald A., Esserman, Laura J.

Volltext

Abstract P3-09-02: Evaluation of a novel agent plus standard neoadjuvant therapy in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL von Liu, Minetta C., Robinson, Patricia A, Yau, Christina, Wallace, Anne M, Chien, A. Jo, Stringer-Reasor, Erica, Nanda, Rita, Yee, Douglas, Albain, Kathy S, Boughey, Judy C, Han, Heather S, Elias, Anthony D, Kalinsky, Kevin, Clark, Amy S, Kemmer, Kathleen, Isaacs, Claudine, Lang, Julie E, Lu, Janice, Sanft, Tara, DeMichele, Angela, Hylton, Nola M, Melisko, Michelle E, Perlmutter, Jane, Rugo, Hope S, Schwab, Richard, Symmans, W. Fraser, van't Veer, Laura J, Haugen, Patricia K, Wilson, Amy, Singhrao, Ruby, Asare, Smita, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Volltext

Abstract CT136: Evaluation of talazoparib in combination with irinotecan in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL von Schwab, Richard, Clark, Amy S., Yau, Christina, Hylton, Nola, Li, Wen, Wolfe, Denise, Chien, A Jo, Wallace, Anne M., Forero-Torres, Andres, Stringer-Reasor, Erica, Nanda, Rita, Jaskowiak, Nora, Boughey, Judy, Haddad, Tufia, Han, Heather S., Lee, Catherine, Albain, Kathy, Isaacs, Claudine, Elias, Anthony D., Ellis, Erin D., Shah, Payal, Lang, Julie E., Lu, Janice, Tripathy, Debasish, Kemmer, Kathleen, Yee, Douglas, Haley, Barbara, Majure, Melanie, Roesch, Erin, Vaklavas, Christos, Ewing, Cheryl, Helsten, Teresa, Symmans, W Fraser, Perlmutter, Jane, Rugo, Hope S., Melisko, Michelle, Wilson, Amy, Singhrao, Ruby, Veer, Laura van 't, DeMichele, Angela, Asare, Smita, Berry, Don, Esserman, Laura J.

Volltext

Abstract PD9-05: Lack of background parenchymal enhancement suppression in breast MRI during neoadjuvant chemotherapy may be associated with inferior treatment response in hormone... von Onishi, Natsuko, Li, Wen, Newitt, David C., Harnish, Roy, Gibbs, Jessica, Jones, Ella F., Nguyen, Alex, Wilmes, Lisa, Joe, Bonnie N., Campbell, Michael J., Basu, Amrita, van’t Veer, Laura J., DiMichele, Angela, Yee, Douglas, Berry, Donald A., Albain, Kathy S., Boughey, Judy C., Chien, A. Jo, Clark, Amy S., Edmiston, Kirsten K., Elias, Anthony D., Ellis, Erin D., Euhus, David M., Han, Heather S., Isaacs, Claudine, Khan, Qamar J., Lang, Julie E., Lu, Janice, Meisel, Jane L., Mitri, Zaha, Nanda, Rita, Northfelt, Donald W., Sanft, Tara, Stringer-Reasor, Erica, Viscusi, Rebecca K., Wallace, Anne M., Yung, Rachel, Melisko, Michelle E., Perlmutter, Jane, Rugo, Hope S., Schwab, Richard, Symmans, W. Fraser, Asare, Smita M., Yau, Julie E., Yau, Christina, Esserman, Laura J., Hylton, Nola M.

Volltext

Abstract GS5-03: Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL von Isaacs, Claudine, Nanda, Rita, Chien, Jo, Trivedi, Meghna S., Stringer-Reasor, Erica, Vaklavas, Christos, Boughey, Judy C., Sanford, Amy, Wallace, Anne, Clark, Amy S., Thomas, Alexandra, Albain, Kathy S., Kennedy, Laura C., Sanft, Tara B., Kalinsky, Kevin, Han, Hyo S., Williams, Nicole, Arora, Mili, Elias, Anthony, Falkson, Carla, Asare, Smita, Lu, Ruixiao, Pitsouni, Maria, Wilson, Amy, Perlmutter, Jane, Rugo, Hope, Schwab, Richard, Symmans, W. Fraser, Hylton, Nola M., Veer, Laura Van’t, Yee, Douglas, DeMichele, Angela, Berry, Donald, Esserman, Laura J., I-SPY Investigators

Volltext

Abstract PD11-01: PD11-01 Evaluation of the PD-1 Inhibitor Cemiplimab in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL von Stringer-Reasor, Erica, Shatsky, Rebecca A., Chien, Jo, Wallace, Anne, Boughey, Judy C., Albain, Kathy S., Han, Hyo S., Nanda, Rita, Isaacs, Claudine, Kalinsky, Kevin, Mitri, Zahi, Clark, Amy S., Vaklavas, Christos, Thomas, Alexandra, Trivedi, Meghna S., Lu, Janice, Asare, Smita, Lu, Ruixiao, Pitsouni, Maria, Wilson, Amy, Perlmutter, Jane, Rugo, Hope, Schwab, Richard, Symmans, W. Fraser, Hylton, Nola M., Van ’t Veer, Laura, Yee, Douglas, DeMichele, Angela, Berry, Donald, Esserman, Laura J., Investigators, I-SPY

Volltext

Treating obsessive-compulsive and tic disorders von Weir, E

Volltext